Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-05T09:30:31.603Z Has data issue: false hasContentIssue false

No mental health without physical health – a call to arms

Published online by Cambridge University Press:  10 March 2016

J. J. McGrath*
Affiliation:
The University of Queensland, Queensland Brain Institute, St. Lucia, Australia Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Richlands, Australia
*
*Address for correspondence: Professor J. McGrath, Queensland Brain Institute, University of Queensland, St Lucia, QLD 4072, Australia and Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Richlands, Australia. (Email: [email protected])
Rights & Permissions [Opens in a new window]

Abstract

Type
Editorials in This Issue
Copyright
Copyright © Cambridge University Press 2016 

This volume includes two invited editorials on the important topic of comorbid physical health in those with serious mental illness (Docherty et al. Reference Docherty, Stubbs and Gaughranin press; Suetani et al. Reference Suetani, Rosenbaum, Scott, Curtis and Wardin press). This field of research has matured substantially over the last two decades, thanks to the hard work of many researchers, who have compiled a solid and consistent body of observational epidemiology. Patients with serious mental disorders (such as schizophrenia) have a shorter life expectancy (Saha et al. Reference Saha, Chant and McGrath2007; Walker et al. Reference Walker, McGee and Druss2015). Those with serious mental disorders such as schizophrenia are more likely to die from suicide, but are also more likely to die from respiratory and cardiometabolic related conditions (Olfson et al. Reference Olfson, Gerhard, Huang, Crystal and Stroup2015). The medications we use to treat mental disorder are associated with increased mortality estimates (Correll et al. Reference Correll, Detraux, De Lepeleire and De Hert2015). When our patients develop comorbid physical disorders, they are less likely to receive optimal health care (Lawrence et al. Reference Lawrence, Hancock and Kisely2013).

In addition to the substantial body of research based on primary data, regular editorials have been appearing on this topic (Mitchell & De Hert, Reference Mitchell and De Hert2015; Stewart, Reference Stewart2015; Suetani et al. Reference Suetani, Whiteford and McGrath2015). This volume of Epidemiology and Psychiatric Sciences contributes to the rise in this metric. What does it say about a field when the ratio of editorials to primary papers increases? It suggests that a particular topic is important. It might also suggest that some type of response from the field is required. The message from the two linked editorials is clear. We need to shift focus into developing better interventions to reduce the burden of physical disorder comorbidity, and we need to invest in health services research and implementation science. We need to ensure that effective treatments are used routinely and become engrained into everyday practice.

There is a danger that sincere and diligent researchers will invest time and research dollars in telling us results that we already know. This is a well-recognized issue for the field of epidemiology – it is called ‘circular epidemiology’ (Kuller, Reference Kuller1999). Kuller describes how a field of research can ‘freeze’ and fail to evolve into applied clinical and service-level interventions. Normally, this type of scientific ‘arrested development’ is not associated with particularly adverse outcomes. However, when the focus of the circular epidemiology is mortality, then the matter becomes more pressing.

Both editorials outline what type of interventions work, and what type of research is needed now. The authors have hard-won experience in this tough area of research. It involves patient-related factors, clinical services and policy factors, and whole-of-society issues. Mindful of how hard it is to shift behaviour in the general population (e.g. smoking, exercise, diet), we need to have a realistic appreciate of what is feasible in the short term. Because it would not be ethical to withhold proven and safe interventions from those with serious mental illnesses, interventions related to reducing adverse physical health outcomes may be better suited to comparative effectiveness studies (e.g. Is proven treatment X cheaper/quicker/more acceptable than proven treatment Y?). And because we know how hard it is roll out these treatments in under-funded services, perhaps we need more investment in interventions that target implementation and service-level reform (e.g. the Recovery After Initial Schizophrenia Episode [RAISE] study, which examined patient and service-level outcomes in cluster-randomised, non-University clinical settings (Correll et al. Reference Correll, Robinson, Schooler, Brunette, Mueser, Rosenheck, Marcy, Addington, Estroff, Robinson, Penn, Azrin, Goldstein, Severe, Heinssen and Kane2014; Kane et al. Reference Kane, Robinson, Schooler, Mueser, Penn, Rosenheck, Addington, Brunette, Correll, Estroff, Marcy, Robinson, Meyer-Kalos, Gottlieb, Glynn, Lynde, Pipes, Kurian, Miller, Azrin, Goldstein, Severe, Lin, Sint, John and Heinssen2015b ; Kane et al. Reference Kane, Schooler, Marcy, Correll, Brunette, Mueser, Rosenheck, Addington, Estroff, Robinson, Penn and Robinson2015a )).

If we do nothing, then we can predict that we will see a further widening of the life expectancy gap between the general population (who are benefitting from public health interventions and better clinical care) v. that of people with severe mental disorder. The widely used mantra of ‘no health without mental health’ needs to be complemented with a commitment to ‘no mental health without physical health’ (Editorial, 2011).

Acknowledgements

J. M. received a John Cade Fellowship APP1056929 from the National Health and Medical Research Council.

Financial support

This research received no specific grant from any funding agency, commercial or not-for-profit sectors.

Conflict of Interest

None.

References

Correll, CU, Robinson, DG, Schooler, NR, Brunette, MF, Mueser, KT, Rosenheck, RA, Marcy, P, Addington, J, Estroff, SE, Robinson, J, Penn, DL, Azrin, S, Goldstein, A, Severe, J, Heinssen, R, Kane, JM (2014). Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study. JAMA Psychiatry 71, 13501363.Google Scholar
Correll, CU, Detraux, J, De Lepeleire, J, De Hert, M (2015). Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 14, 119136.CrossRefGoogle ScholarPubMed
Docherty, M, Stubbs, B, Gaughran, F (in press). Strategies to deal with comorbid physical illness in psychosis. Epidemiology and Psychiatric Sciences. doi: 10.1017/S2045796016000056.Google Scholar
Editorial (2011). No mental health without physical health. The Lancet 9766.Google Scholar
Kane, JM, Schooler, NR, Marcy, P, Correll, CU, Brunette, MF, Mueser, KT, Rosenheck, RA, Addington, J, Estroff, SE, Robinson, J, Penn, DL, Robinson, DG (2015 a). The RAISE early treatment program for first-episode psychosis: background, rationale, and study design. Journal of Clinical Psychiatry 76, 240246.Google Scholar
Kane, JM, Robinson, DG, Schooler, NR, Mueser, KT, Penn, DL, Rosenheck, RA, Addington, J, Brunette, MF, Correll, CU, Estroff, SE, Marcy, P, Robinson, J, Meyer-Kalos, PS, Gottlieb, JD, Glynn, SM, Lynde, DW, Pipes, R, Kurian, BT, Miller, AL, Azrin, ST, Goldstein, AB, Severe, JB, Lin, H, Sint, KJ, John, M, Heinssen, RK (2015 b). Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program. American Journal of Psychiatry. appiajp201515050632.Google ScholarPubMed
Kuller, LH (1999). Circular epidemiology. American Journal of Epidemiology 150, 897903.Google Scholar
Lawrence, D, Hancock, KJ, Kisely, S (2013). The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ 346, f2539.Google Scholar
Mitchell, AJ, De Hert, M (2015). Promotion of physical health in persons with schizophrenia: can we prevent cardiometabolic problems before they begin? Acta Psychiatrica Scandinavica 132, 8385.Google Scholar
Olfson, M, Gerhard, T, Huang, C, Crystal, S, Stroup, TS (2015). Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry 110.Google Scholar
Saha, S, Chant, D, McGrath, J (2007). A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Archives of General Psychiatry 64, 11231131.Google Scholar
Stewart, R (2015). Mental disorders and mortality: so many publications, so little change. Acta Psychiatrica Scandinavica 132, 410411.Google Scholar
Suetani, S, Whiteford, HA, McGrath, JJ (2015). An urgent call to address the deadly consequences of serious mental disorders. JAMA Psychiatry 12.Google ScholarPubMed
Suetani, S, Rosenbaum, S, Scott, J, Curtis, J, Ward, PB (in press). Bridging the gap: what have we done, and what more can we do to reduce the burden of avoidable death in people with psychotic illness? Epidemiology and Psychiatric Sciences. doi: 10.1017/S2045796015001043.Google Scholar
Walker, ER, McGee, RE, Druss, BG (2015). Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry 72, 334341.Google Scholar